10.1016/j.nbd.2021.105510 Neurobiol
One user reported using semaglutide from Willow for five months at increasing doses with increasing prices, ultimately gaining five pounds and doubting whether the medication contained the actual drug
Great insights and results
Many patients using tirzepatide see reductions in total cholesterol, LDL cholesterol (bad cholesterol), and triglycerides, along with potential increases in HDL cholesterol (good cholesterol)
Those included various baseline characteristic including demographics (age, gender, race), comorbidities (e.g., liver diseases, chronic lower respiratory diseases, diabetic complications, obesity and neoplasm), medications (e.g., insulin, metformin, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), tacrolimus, cyclosporine, mycophenolate mofetil (MMF), and corticosteroids), as well as laboratory tests and physical findings (e.g., hemoglobin, glycated hemoglobin (HbA1c) levels, lipid profile, estimated glomerular filtration rate (eGFR) and systolic blood pressure (SBP))
Best For: Those who want a behaviorally focused program that combines psychology, coaching, and GLP-1 medication support